People: Acceleron Pharma Inc (XLRN.O)

XLRN.O on Consolidated Issue listed on NASDAQ Global Market

40.50USD
26 Dec 2014
Price Change (% chg)

$1.70 (+4.38%)
Prev Close
$38.80
Open
$39.17
Day's High
$40.50
Day's Low
$39.00
Volume
135,153
Avg. Vol
308,851
52-wk High
$57.89
52-wk Low
$23.61

Search Stocks

KNOPF, JOHN 

Brief Biography

Dr. John Knopf is President, Chief Executive Officer, Director of Acceleron Pharma, Inc. He co-founded Acceleron in 2003 and is our Chief Executive Officer and President. Dr. Knopf served on our board of directors from 2003 to 2004, and has served from 2007 to the present. Prior to founding Acceleron, Dr. Knopf served as Site Head of the Wyeth Research facilities in Cambridge, MA and Vice President of Metabolic and Respiratory Disease. Dr. Knopf was an early key scientist at Genetics Institute (GI) from 1982 to 1998, where he participated in the development of pioneering biopharmaceutical products including the first treatment for hemophilia, recombinant factor VIII Recombinate® and helped establish GI as a premier biopharmaceutical company. While at GI, he established a structure-based small molecule discovery group. Dr. Knopf is the author of several key scientific manuscripts in the area of signal transduction, and is named as an inventor of several patents. Dr. Knopf received a BS in biology from SUNY Stonybrook and his Ph.D. in biology at SUNY Buffalo. We believe Dr. Knopf's extensive experience and knowledge of biopharmaceuticals and our company qualifies him to serve as a member of our board of directors.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
400,000 -- 2,233,880 2,633,880

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

JOHN KNOPF

2,633,880

Kevin McLaughlin

--

Steven Ertel

--

MATTHEW SHERMAN

999,216

Ravindra Kumar

--

John Quisel

910,219
As Of 30 Dec 2013
Search Stocks